Curated News: Medical Meetings

Filters close
14-Apr-2023 1:55 PM EDT
Study: Drug May Delay Earliest Symptoms of Multiple Sclerosis
American Academy of Neurology (AAN)

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease. The preliminary study, released April 19, 2023, will be presented at the American Academy of Neurology’s 75th Annual Meeting, being held in person in Boston and live online from April 22-27, 2023. Called radiologically isolated syndrome, the condition is diagnosed in people who do not have MS symptoms but who have abnormalities in the brain or spinal cord called lesions, similar to those seen in MS.

Released: 19-Apr-2023 1:00 PM EDT
Johns Hopkins Malaria Research Institute Hosting World Malaria Day Symposium on Tuesday, April 25
Johns Hopkins Bloomberg School of Public Health

The Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health will host its annual World Malaria Day Symposium Tuesday, April 25, from 8:30 a.m. to 5:45 p.m. EDT. The theme is the blood stage of malaria, which is the most devastating phase of the disease. The event will take place in person in Baltimore with thirteen panelists. A remote option is available to journalists.

Newswise:Video Embedded staying-safe-when-it-s-hot-study-identifies-temperature-humidity-combinations-that-stress-the-heart
VIDEO
12-Apr-2023 4:25 PM EDT
Staying Safe When It’s Hot: Study Identifies Temperature-humidity Combinations that Stress the Heart
American Physiological Society (APS)

A new study shows that cardiovascular strain begins at lower temperature and humidity levels than those that cause increases in the body’s core temperature, and could inform revisions to safety guidelines and policies that help protect people during heat waves.

   
14-Apr-2023 1:50 PM EDT
Could Fixing a Problem with the Heart Be Good for Your Brain?
American Academy of Neurology (AAN)

People who have an irregular heartbeat called atrial fibrillation that is treated with a procedure called catheter ablation may have a reduced risk of dementia compared to those who are treated with medication alone. The preliminary study released April 18, 2023, will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

Newswise:Video Embedded trying-to-lower-blood-pressure-evening-exercise-might-be-best
VIDEO
12-Apr-2023 4:15 PM EDT
Trying to Lower Blood Pressure? Evening Exercise Might Be Best  
American Physiological Society (APS)

A new study of elderly patients showed that those who exercised in the evening experienced a greater decrease in blood pressure compared to those who exercised in the morning.

Newswise:Video Embedded fat-isn-t-necessarily-bad-full-fat-yogurt-helps-lower-glucose-levels-in-people-with-prediabetes
VIDEO
12-Apr-2023 3:25 PM EDT
Fat Isn’t Necessarily Bad! Full-fat Yogurt Helps Lower Glucose Levels in People with Prediabetes
American Physiological Society (APS)

Researchers from the University of Vermont have found that eating full-fat yogurt on a daily basis may help lower fasting glucose levels in middle-age and older adults with prediabetes.

Released: 18-Apr-2023 12:05 PM EDT
Severe COVID-19 linked with 16-fold risk of life-threatening heart rhythm within 6 months
European Society of Cardiology

Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without severe infection, according to research presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).1 Risks of other heart rhythm disorders were also elevated.

Newswise: New Research Shows E-Cigarette Use Up Sharply Among Younger Adults in U.S. During EVALI Outbreak and COVID-19 Pandemic
16-Apr-2023 8:05 PM EDT
New Research Shows E-Cigarette Use Up Sharply Among Younger Adults in U.S. During EVALI Outbreak and COVID-19 Pandemic
American Cancer Society (ACS)

A new study by researchers at the American Cancer Society (ACS) shows almost three-quarters of a million more adults in the United States, ages 18-29 years, used e-cigarettes between 2019-2021 during the period that spanned the EVALI outbreak (E-cigarette or vaping product use–associated lung injury) and COVID-19 pandemic.

Newswise: AACR: Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types
14-Apr-2023 12:05 PM EDT
AACR: Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple clinical trials today at the American Association for Cancer Research (AACR) Annual Meeting 2023. The studies, which describe results from a novel FGFR inhibitor and from new PARP/ATR inhibitor combinations, were featured in a plenary session highlighting novel biomarker-driven molecularly targeted therapy trials.

Released: 18-Apr-2023 10:05 AM EDT
FTD/TPI Plus Oxaliplatin Well-Tolerated But Not Broadly Effective as Treatment for Esophageal Cancer
Roswell Park Comprehensive Cancer Center

Research led by Roswell Park's Sarbajit Mukherjee, MD, MS, shows that a new chemotherapy combination — trifluridine/tipiracil (FTD/TPI) and oxaliplatin — is well tolerated and has activity among patients with esophageal cancer.

Released: 18-Apr-2023 10:05 AM EDT
From AACR 2023: Roswell Park Researchers Highlight Patient, Survivor Survey on Cannabis
Roswell Park Comprehensive Cancer Center

Results of an anonymous cancer patient and survivor survey conducted by a team from Roswell Park Comprehensive Cancer Center’s Center for Translational Research on Cannabis and Cancer (CTRCC) will be shared at the American Association for Cancer Research 2023 Annual Meeting in Orlando.

Newswise: Benefit of Chemotherapy for Patients With Early-Stage Breast Cancer Varies by Tumor Anatomy
Released: 18-Apr-2023 10:05 AM EDT
Benefit of Chemotherapy for Patients With Early-Stage Breast Cancer Varies by Tumor Anatomy
Roswell Park Comprehensive Cancer Center

Based on a large retrospective study, Roswell Park Comprehensive Cancer Center experts that many patients with early-stage breast cancer with rare variant histology, or tumor anatomy, benefit from chemotherapy.

Newswise: How is TikTok affecting our mental health? It’s complicated, new U of M study shows
Released: 18-Apr-2023 7:00 AM EDT
How is TikTok affecting our mental health? It’s complicated, new U of M study shows
University of Minnesota College of Science and Engineering

University of Minnesota Twin Cities computer science researchers found that the nature of TikTok’s algorithm can have both positive and negative outcomes for users’ mental health and sense of belonging on the platform.

   
Newswise: ISPOR Announces Real-World Evidence Summit 2023
Released: 18-Apr-2023 4:05 AM EDT
ISPOR Announces Real-World Evidence Summit 2023
ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its ISPOR Real-World Evidence Summit 2023 scheduled for May 7 in Boston, MA, USA.

Released: 17-Apr-2023 2:30 PM EDT
Ketamine May Be More Effective in Reducing Postoperative Pain in Patients With a Higher TSP
American Society of Regional Anesthesia and Pain Medicine (ASRA)

A study has found that ketamine may be more helpful in preventing postoperative pain among a subset of patients with a higher tendency toward central sensitization as measured by TSP (temporal summation of pain).

Released: 17-Apr-2023 2:30 PM EDT
TNS Development After HoLEP Surgery May Be Influenced by Patient Positioning, Procedure Duration, and Patient Characteristics
American Society of Regional Anesthesia and Pain Medicine (ASRA)

A retrospective chart review found a 3.7% occurrence rate of transient neurologic symptoms (TNS) in patients receiving 1.5% mepivacaine during Holmium Laser Enucleation of the Prostate (HoLEP) surgery and suggested a possible association of TNS development with quicker procedures, smaller prostates, lithotomy positioning, and younger age.

Released: 17-Apr-2023 2:30 PM EDT
Dual Nerve Block May Provide Superior Pain Control During Breast Cancer Surgery, Reduce Risk of Chronic Pain
American Society of Regional Anesthesia and Pain Medicine (ASRA)

Using two targeted injections of local anesthetic medication may provide a comprehensive, effective means of pain control during breast cancer surgery, found a study by researchers at Western University, London, Ontario, Canada.

Released: 17-Apr-2023 2:30 PM EDT
Infection Risk Is Rare With Epidural and Spinal Blocks, Higher With Peripheral Nerve Block Catheters
American Society of Regional Anesthesia and Pain Medicine (ASRA)

A review of medical literature found that infections following epidural and spinal blocks are rare. Infections following peripheral nerve block catheters are more common but have been less frequently studied; this may necessitate a review of patient and procedural aspects to lower the risk associated with these procedures.

Newswise: Use of Nerve Stimulation During Adductor Canal Block Could Help Identify and Avoid Injury to Nerve to Vastus Medialis
Released: 17-Apr-2023 2:30 PM EDT
Use of Nerve Stimulation During Adductor Canal Block Could Help Identify and Avoid Injury to Nerve to Vastus Medialis
American Society of Regional Anesthesia and Pain Medicine (ASRA)

A study using lower limbs from two cadavers to demonstrate the technique of adductor canal (AC) block found that the needle trajectory of the traditional approach led to impalement of the nerve to vastus medialis (NVM) in 33% of cases and direct contact with the nerve in another 22%.

Newswise: AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
13-Apr-2023 3:35 PM EDT
AACR: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
University of Texas MD Anderson Cancer Center

A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.

Released: 17-Apr-2023 2:15 PM EDT
Location intelligence shines a light on disinformation
Oak Ridge National Laboratory

Using disinformation to create political instability and battlefield confusion dates back millennia. However, today’s disinformation actors use social media to amplify disinformation that users knowingly or, more often, unknowingly perpetuate. Such disinformation spreads quickly, threatening public health and safety. Indeed, the COVID-19 pandemic and recent global elections have given the world a front-row seat to this form of modern warfare.

   
Released: 17-Apr-2023 1:40 PM EDT
IU cancer center researcher leads first in-human multiple myeloma study with 90.5 percent response rate
Indiana University

Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of the immunotherapy called REGN5459 resulted in a 90.5 percent overall response rate.

Released: 17-Apr-2023 12:05 PM EDT
Effect of COVID-19 pandemic on mortality in people with intellectual disabilities extended beyond deaths from COVID itself
European Society of Clinical Microbiology and Infectious Diseases

New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (Copenhagen, 15-18 April) and published in The Lancet Public Health shows that the impact of COVID-19 on mortality in people living with intellectual disabilities extended beyond deaths from the virus itself, and was linked with increased mortality in several other conditions.

14-Apr-2023 7:00 AM EDT
AACR: Novel allogeneic CAR T cell therapy delivers promising early results in patients with metastatic clear cell renal cell carcinoma
University of Texas MD Anderson Cancer Center

The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and disease control rates in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2023.

Released: 17-Apr-2023 8:05 AM EDT
American Association of Neurological Surgeons to Showcase New Science at the 2023 AANS Annual Scientific Meeting
American Association of Neurological Surgeons (AANS)

New, never before presented research will be shared during the 2023 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles. The late-breaking abstract “Efficacy and Safety of Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): a Multicenter Randomized Adaptive Trial,” will be showcased during the Plenary Session l, Saturday, April 22, at 9:39 am- 9:49 am, PST.

Newswise: ISPOR 2023 Plenaries and Speakers Announced
Released: 17-Apr-2023 4:05 AM EDT
ISPOR 2023 Plenaries and Speakers Announced
ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA.

Newswise: AACR: YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers
14-Apr-2023 12:00 PM EDT
AACR: YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers
University of Texas MD Anderson Cancer Center

The first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with advanced malignant mesothelioma and other tumors with NF2 mutations, according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.

14-Apr-2023 12:00 PM EDT
AACR: Penn Medicine Preclinical Study Identifies New Target for Recurrent Ovarian Cancer
Perelman School of Medicine at the University of Pennsylvania

Results from a preclinical study from Penn Medicine, presented at the AACR Annual Meeting 2023, verified a new target for drug-resistant ovarian cancer and provided data to support a treatment approach that is already making its way into clinical trials.

Newswise: AACR: Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
13-Apr-2023 3:40 PM EDT
AACR: Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery
University of Texas MD Anderson Cancer Center

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.

Newswise: MSK Experts To Receive Prestigious Awards at the American Association for Cancer Research (AACR) 2023 Annual Meeting
Released: 14-Apr-2023 2:00 PM EDT
MSK Experts To Receive Prestigious Awards at the American Association for Cancer Research (AACR) 2023 Annual Meeting
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute, will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care

Released: 14-Apr-2023 12:00 PM EDT
Penn Medicine at the AACR Annual Meeting 2023
Perelman School of Medicine at the University of Pennsylvania

Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances across the full spectrum of cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2023 from April 14-19 in Orlando, Florida.

Released: 13-Apr-2023 1:30 PM EDT
Higher dose corticosteroids associated with a 60% increased risk of death in hypoxic COVID-19 patients requiring only non-invasive oxygen therapy
European Society of Clinical Microbiology and Infectious Diseases

A new study to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen 15-18 April), and published in The Lancet, shows that, compared with standard care that included low dose corticosteroid use, treating hypoxic COVID-19 patients needing only oxygen therapy or no breathing support with higher dose corticosteroids is associated with a 60% increased risk of death.

Released: 13-Apr-2023 8:05 AM EDT
The 2023 American Association of Neurological Surgeons Annual Scientific Meeting Features Never-Before-Presented Research
American Association of Neurological Surgeons (AANS)

The American Association of Neurological Surgeons (AANS) Annual Meeting will be the first ever to showcase the late-breaking abstract “Decompressive Craniectomy vs Craniotomy for Traumatic Acute Subdural Hematoma” Sunday, April 23, at 9:10 am-9:18 am, during Plenary Session ll.

Newswise: Opioid Exposure in the Womb Could Raise the Risk of Heart Disease Later in Life
Released: 13-Apr-2023 7:00 AM EDT
Opioid Exposure in the Womb Could Raise the Risk of Heart Disease Later in Life
American Physiological Society (APS)

A new study sheds light on an understudied aspect of today’s opioid crisis: What happens to the cardiovascular health of babies exposed to opioids in the womb.

   
Released: 12-Apr-2023 12:35 PM EDT
AACR 2023: Ohio State experts share new findings on immuno-oncology, ‘smart-drugs,’ obesity-related endometrial cancers and other research topics
Ohio State University Wexner Medical Center

New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.

Released: 12-Apr-2023 12:00 PM EDT
MD Anderson Research Highlights: AACR 2023 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2023.

   
Newswise: American Cancer Society Scientists to Present Research at AACR Annual Meeting
Released: 12-Apr-2023 10:05 AM EDT
American Cancer Society Scientists to Present Research at AACR Annual Meeting
American Cancer Society (ACS)

American Cancer Society researchers are headed to Orlando, Florida this week for the annual meeting of the American Association of Cancer Research.

Newswise: NCCN Annual Conference Brings Up Important Questions for Improving Cancer Care
Released: 12-Apr-2023 8:30 AM EDT
NCCN Annual Conference Brings Up Important Questions for Improving Cancer Care
National Comprehensive Cancer Network® (NCCN®)

The NCCN 2023 Annual Conference took place in-person in Orlando and virtually, with a particular focus on human connection. That connection was underscored with more than 2,000 registrants from across the continuum of cancer care, including approximately 1,000 who returned in-person for the first time since 2019. Educational sessions highlighted the importance of ensuring care meets the latest standards while also rejecting a one-size-fits-all approach.

Newswise: St. Jude scientists to receive coveted awards at AACR annual meeting
Released: 11-Apr-2023 4:30 PM EDT
St. Jude scientists to receive coveted awards at AACR annual meeting
St. Jude Children's Research Hospital

The American Association of Cancer Research (AACR) will honor two investigators from St. Jude Children’s Research Hospital for their research contributions. Melissa Hudson, M.D., director of the Cancer Survivorship Division and Jun J. Yang, Ph.D., vice-chair of Pharmacy and Pharmaceutical Sciences

Newswise: Cedars-Sinai Cancer Experts To Present Clinical Findings at AACR Conference
Released: 11-Apr-2023 11:05 AM EDT
Cedars-Sinai Cancer Experts To Present Clinical Findings at AACR Conference
Cedars-Sinai

Cedars-Sinai Cancer oncologists and researchers are available to comment on late-breaking topics and research throughout the American Association for Cancer Research (AACR) Annual Meeting 2023, happening April 14-19 in Orlando.

Released: 11-Apr-2023 9:00 AM EDT
Press passes now available for NUTRITION 2023 to be held July 22–25 in Boston
American Society for Nutrition (ASN)

Complimentary press passes are now available for NUTRITION 2023, the annual flagship meeting of the American Society for Nutrition. Join us July 22-25 in Boston to hear about the latest developments in nutrition research, practice, and policy.

Released: 11-Apr-2023 8:05 AM EDT
2023 American Association of Neurological Surgeons Annual Scientific Meeting Highlights Latest Technology that Translates Thoughts Into Text at Record-Breaking Speeds
American Association of Neurological Surgeons (AANS)

The American Association of Neurological Surgeons (AANS) Annual Meeting is known for showcasing the latest research, science and technology, and this year is no exception in Los Angeles. The late-breaking abstract “An Intracortical Speech BCI for High-Performance Brain-to-Text Communication” will be shared during the Opening Session, Friday, April 21, at 5:30 pm-5:38 pm, PST.

   
Newswise: Yale Cancer Center experts to present new research at annual AACR Meeting
Released: 10-Apr-2023 7:05 AM EDT
Yale Cancer Center experts to present new research at annual AACR Meeting
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians and scientists are presenting research studies at the 2023 American Association for Cancer Research (AACR) Annual Meeting at the Orange County Convention Center in Orlando, Florida, April 14 to 19th.

Released: 4-Apr-2023 1:45 PM EDT
AI tool gains doctors’ trust by giving advice like a colleague
Cornell University

A new Cornell University-led study suggests that if artificial intelligence tools can counsel a doctor like a colleague – pointing out relevant research that supports the decision – then doctors can better weigh the merits of the recommendation.

   
Newswise: Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease
Released: 3-Apr-2023 5:15 PM EDT
Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease
University of North Carolina Health Care System

A significant clinical trial under the direction of Michael Kappelman, MD, MPH, professor of pediatrics at UNC School of Medicine, found that patients receiving the tumor necrosis factor inhibitor adalimumab combined with a low dose of methotrexate, a second immunosuppressant, did better than those treated with infliximab alone. Patients who received infliximab, another tumor necrosis factor inhibitor, had similar outcomes with or without methotrexate.

20-Mar-2023 11:45 PM EDT
Obesity treatment could offer dramatic weight loss without surgery or nausea
American Chemical Society (ACS)

Imagine getting the benefits of gastric bypass surgery without going under the knife. A new class of potential treatments has done that in lab animals, reducing weight dramatically and lowering blood glucose without side effects, scientists report. They will present their results at ACS Spring 2023.

   
20-Mar-2023 11:45 PM EDT
ACS Spring 2023 Media Briefing Schedule
American Chemical Society (ACS)

Recordings of media briefings will be posted by 10 a.m. Eastern Time on each day. Watch recorded media briefings at: www.acs.org/ACSSpring2023briefings.

   
20-Mar-2023 9:00 AM EDT
New insights into how cells respond to altered gravity experienced in space
American Society for Biochemistry and Molecular Biology (ASBMB)

A new study has revealed insights into how cells sense and respond to the weightlessness experienced in space. The information could be useful for keeping astronauts healthy on future space missions.

   


close
2.48441